Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay

Journal of Neuroscience Methods

Volumn 80, Issue 1, 1998, Pages 99-105

  Ardati, Ali ^a   Gottowik, Juergen ^a   Henriot, Stephane ^a   Clerc, Roger G ^a   Kilpatrick, Gavin J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

3H Urocortin; CRF; CRF binding protein; CRH

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; HORMONE BINDING PROTEIN; SAUVAGINE; UROCORTIN; UROTENSIN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; HORMONE ACTION; HORMONE BINDING; LIGAND BINDING; PRIORITY JOURNAL;

BINDING, COMPETITIVE; CARRIER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; KINETICS; RADIOLIGAND ASSAY; RECOMBINANT PROTEINS; SODIUM DODECYL SULFATE; TRITIUM;

EID: 0032513346     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00210-0     Document Type: Article

References (24)

1. Behan D.P., Linton E.A., Lowry P.J. Isolation of the human plasma corticotropin releasing factor binding protein. J Endocrinol. 122:1988;23-31.
2. Behan D.P., Potter E., Sutton S., Fischer W., Lowry P.J., Vale W.W. Corticotropin-releasing factor-binding protein: A putative peripheral and central modulator of the CRF family of neuropeptides. Ann New York Acad Sci. 697:1993;1-8.
3. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., Vale W.W. Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides. Front Neuroendocrinol. 16:1995;362-382.
4. Behan D.P., Heinrichs S.C., Tronscoso J.C., Liu X.-J., Kawas C.H., Ling N., De Souza E.B. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature. 378:1995;284-287.
5. Behan D.P., Cepoi D., Fischer W.H., Park M., Sutton S., Lowry P.J., Vale W.W. Characterization of a sheep brain corticotropin releasing factor binding protein. Brain Res. 709:1996;265-274.
6. Behan D.P., Khongsaly O., Ling N., De Souza E.B. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating 'free' CRF levels in human brain. Brain Res. 725:1996;263-267.
7. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotropin-releasing factor receptors: from molecular biology to drug discovery. Trends Pharmacol Sci. 12:1996;166-172.
8. Cortright D.N., Nicoletti A., Seasholtz A.F. Molecular and biochemical characterisation of the mouse brain corticotropin-releasing hormone-binding protein. Mol Cell Endocrinol. 111:1995;147-157.
9. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
10. 3H]urocortin. Neuropharmacology. 36:1997;1439-1446.
11. Heinrichs S.C., Lapsanky J., Behan D.P., Chan R.K.W., Sawchenko P.E., Lorang M., Ling N., Vale W.W., De Souza E.B. Corticotropin-releasing factor-binding protein ligand inhibitor blunts excess weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci U S A. 93:1996;15475-15480.
12. 3H] piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites. J Neurochem. 46:1986;413-421.
13. Lennon G.G., Auffray C., Polymeropoulos M., Soares M.B. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics. 33:1996;151-152.
14. Linton E.A., Wolfe C.D.A., Behan D.P., Lowry P.J. A specific carrier substance for human corticotropin-releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin Endocrinol. 28:1988;315-324.
15. McPherson GA. KINETIC, EBDA, LIGAND, LOWRY. A Collection of Radioligand Binding Analysis Programs. Cambridge, UK: Biosoft, 1985.
16. Munson P.J., Rodbard D. Ligand: a versatile computerised approach for characterisation of ligand-binding systems. Anal Biochem. 107:1980;220-230.
17. Niswender G.D., Akabr A.M., Nett T.M. The use of specific antibodies for quantification of steroid hormones. Methods Enzymol. 36:1975;16-34.
18. Owens MJ, Nemeroff CB. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. In: Chadwick DJ, Marsh J, Ackrill K, editors. Corticotropin-releasing Factor. Chichester: Wiley, 1993:296-316.
19. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., Vale W.W. Cloning and characterisation of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature. 349:1991;423-426.
20. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A. 89:1992;4192-4196.
21. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley III F.D., Winston E.N., Chen Y.L., Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A. 93:1996;10477-10482.
22. Schumpp E., Schlaeger E.-J. Optimization of culture conditions for high cell density proliferation of HL-60 human promyelocytic leukemia cells. J Cell Sci. 97:1990;639-647.
23. Suda T., Iwashita M., Tozawa F., Ushiyama T., Tomori N., Sumitomo T., Nakagami Y., Demura H., Shizume K. Characterisation of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J Clin Endocrinol Metab. 67:1988;1278-1283.
24. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko J., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin releasing factor. Nature. 378:1995;287-292.